SecSonar.com

Star Equity Holdings, Inc. (STRR)

Star Equity Holdings, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Star Equity Holdings, Inc. (STRR) is a Medical - Diagnostics & Research company based in US with a market capitalization of $42.6M. Revenue grew 222.6% year-over-year and free cash flow was negative at -$9M. This page tracks STRR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 194 employees · IPO Jun 10, 2004

Valuation

Valuation & price

$9.73 · as of May 17, 2026 · -17.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.65

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$11.80$10.11$8.41Jul 25Dec 25Jul 26Jul 7, 25$8.41Jul 9, 25$8.53Jul 11, 25$8.65Jul 15, 25$8.47Jul 17, 25$8.80Jul 21, 25$8.93Jul 23, 25$9.01Jul 25, 25$9.33Jul 29, 25$9.15Jul 31, 25$8.97Aug 4, 25$8.70Aug 6, 25$9.11Aug 11, 25$8.80Aug 13, 25$9.20Aug 15, 25$9.19Aug 19, 25$9.13Aug 21, 25$8.99Aug 25, 25$8.67Aug 27, 25$9.45Aug 29, 25$9.41Sep 3, 25$9.87Sep 5, 25$9.44Sep 9, 25$9.27Sep 11, 25$8.54Sep 16, 25$10.20Sep 18, 25$11.57Sep 22, 25$11.31Sep 24, 25$11.61Sep 26, 25$11.40Sep 30, 25$11.12Oct 2, 25$11.27Oct 6, 25$11.80Oct 8, 25$11.14Oct 10, 25$11.11Oct 14, 25$11.13Oct 16, 25$10.78Oct 21, 25$11.01Oct 23, 25$10.93Oct 27, 25$10.95Oct 29, 25$11.25Oct 31, 25$10.96Nov 4, 25$10.90Nov 6, 25$10.25Nov 10, 25$10.13Nov 12, 25$10.18Nov 14, 25$10.33Nov 18, 25$10.31Nov 20, 25$9.65Nov 25, 25$10.00Nov 28, 25$10.15Dec 2, 25$10.10Dec 4, 25$10.08Dec 8, 25$10.43Dec 10, 25$10.36Dec 12, 25$10.66Dec 16, 25$11.11Dec 18, 25$10.93Dec 22, 25$11.00Dec 24, 25$10.93Dec 29, 25$11.27Jan 2, 26$10.67Jan 6, 26$10.87Jan 8, 26$10.73Jan 12, 26$10.85Jan 14, 26$10.66Jan 16, 26$10.96Jan 21, 26$10.62Jan 23, 26$10.14Jan 27, 26$10.26Jan 29, 26$10.35Feb 2, 26$10.20Feb 4, 26$10.03Feb 9, 26$9.90Feb 11, 26$9.99Feb 13, 26$10.15Feb 18, 26$10.01Feb 20, 26$10.05Feb 24, 26$9.80Feb 26, 26$9.88Mar 2, 26$9.83Mar 4, 26$9.93Mar 6, 26$10.07Mar 10, 26$9.87Mar 12, 26$9.91Mar 17, 26$9.70Mar 19, 26$9.92Mar 23, 26$9.69Mar 25, 26$9.71Mar 27, 26$10.10Mar 31, 26$10.28Apr 2, 26$9.75Apr 7, 26$9.53Apr 9, 26$9.67Apr 13, 26$9.63Apr 15, 26$9.61Apr 17, 26$9.65Apr 22, 26$9.50Apr 24, 26$9.45Apr 28, 26$9.89Apr 30, 26$9.70May 4, 26$9.57May 6, 26$9.40May 8, 26$9.46May 12, 26$9.77May 14, 26$9.96May 18, 26$9.70May 20, 26$10.50May 22, 26$11.48May 28, 26$11.55Jun 1, 26$11.71Jun 3, 26$11.55Jun 5, 26$11.30Jun 9, 26$11.06Jun 11, 26$11.34Jun 15, 26$11.02Jun 17, 26$11.08Jun 22, 26$11.25Jun 24, 26$11.04Jun 26, 26$10.94Jul 2, 26$10.99
$8.3852-week range$11.81
Loading valuation history…

Fundamentals

Key fundamentals

$42.6M

Market cap

222.6%

Revenue growth (YoY)

45.7%

Gross margin

-$9M

Free cash flow (USD)

$10.6M

Net debt

1.7%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$125.5MFY 2017$118.3MFY 2018$104.2MFY 2019$72.9MFY 2020$78.2MFY 2021$106.6MFY 2022$112.2MFY 2023$161.3MFY 2024$53.4MFY 2025$172.2M
$125.5M$172.2M

Free cash flow by year

2016 → 2025

FY 2016$4.6MFY 2017$3.7MFY 2018$2.9MFY 2019$-6.3MFY 2020$-6.4MFY 2021$-7.2MFY 2022$-5.0MFY 2023$2.0MFY 2024$-8.0MFY 2025$-9.0M
$4.6M-$9M

Gross margin by year

2021 → 2025

FY 202114.3%FY 202223.1%FY 202349.8%FY 202420.7%FY 202545.7%
14.3%45.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

17

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider buyInsider Buy $110KEberwein Jeffrey E. · Director, Chief Executive Officer, 10% Owner · $110.1KJun 29, 2026Filing
  • 8-K eventIndex InclusionJun 29, 2026Filing
  • Insider buyInsider Buy $56KEberwein Jeffrey E. · Director, Chief Executive Officer, 10% Owner · $55.8KJun 23, 2026Filing
  • Insider buyInsider Buy $56KEberwein Jeffrey E. · Director, Chief Executive Officer, 10% Owner · $56KJun 17, 2026Filing
  • Insider buyInsider Buy $12KDrake Mimi K · Director · $11.7KJun 15, 2026Filing
  • Insider buyInsider Buy $6KFruhbeis Todd Michael · Director · $5.6KJun 15, 2026Filing
  • Insider buyInsider Buy $21KEberwein Jeffrey E. · Director, Chief Executive Officer, 10% Owner · $20.5KJun 12, 2026Filing
  • Insider buyInsider Buy $3KFruhbeis Todd Michael · Director · $2.9KJun 12, 2026Filing
  • Insider buyInsider Buy $6KPearse Robert G. · Director · $5.7KJun 9, 2026Filing
  • Insider buyInsider Buy $8KPalmer Jennifer · Director · $8KJun 9, 2026Filing

Questions

Frequently asked questions

What is Star Equity Holdings, Inc.'s market cap?

Star Equity Holdings, Inc. (STRR) has a market capitalization of $42.6M.

What is STRR's P/E ratio?

A meaningful P/E ratio is not available for STRR — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is STRR's price-to-book (P/B) ratio?

STRR trades at 0.65 times book value per share.

Are insiders buying STRR stock?

Yes — SEC Form 4 filings show 17 open-market insider buys and 0 sells at Star Equity Holdings, Inc. in the last 90 days.

Same arena

Related companies in Medical - Diagnostics & Research

PRPO

Precipio, Inc.

$41.6M

MDXH

MDxHealth S.A.

$40.5M

QUCY

Mainz Biomed N.V.

$33.5M

DRIO

DarioHealth Corp.

$55.2M

VNRX

VolitionRx Limited

$15.6M

NOTV

Inotiv, Inc.

$9.8M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.